Ensuring Drug Security Forum

Rare Diseases. Innovative Approaches to Therapy and Patient Care and the Establishment of Domestic Orphan Drug Production

05 Jun , 14:30–16:00
‘Ensuring Drug Security’ Russian Pharmaceutical Forum
Congress Centre, zone D, conference hall D4

Orphan diseases are a heavy medical and social burden for any state. Roughly 70% of orphan diseases are genetic, progressive, and lead to either disability or early mortality. Moreover, the rarity of such diseases is what causes problems with their diagnosis. Insufficient data about them prevents us from determining their prevalence and, as such, does not provide pharmaceutical companies with the opportunity to forecast the potential market and the efficiency of investments. Some countries struggle to conduct local clinical trials due to their low number of patients with orphan diseases. These factors limit the ability to provide drugs to patients with orphan diseases. To expand such opportunities and jumpstart the market for innovative orphan drugs, it is crucial to strengthen tools for international cooperation, from developing therapies, conducting full-scale clinical studies, collecting and analysing data from real clinical practice, and creating common registries, to consolidating demand and developing mechanisms for joint international procurements. Given the economic sanctions in Russia, the problem of access to innovative pharmaceutical technologies must be solved by improving national technological sovereignty. How can we ensure the creation of domestic developments for molecular genetic research into orphan diseases? How can we promote the creation of patient registries? What regulatory and financial practices could stimulate the development of innovative orphan drugs? How can we ensure the availability of orphan drugs, including for adult patients? What effective tools to support the provision of orphan drugs can be borrowed from international experience?

Moderators
Sergey Kutsev, Director, Academician N.P. Bochkov Medical Genetic Research Center; Chief Freelance Specialist in Medical Genetics of the Ministry of Health of Russia
Tatyana Pervunina, Director of the Institute of Perinatology and Pediatrics, V.A. Almazov National Medical Research Center of the Ministry of Health of the Russian Federation

Panellists
Dmitriy Galkin, Director of Department of Pharmaceutical and Medical Industry Development, Ministry of Industry and Trade of the Russian Federation
Yury Zhulev, President, Russian Hemophilia Society
Guvenc Kockaya, General Director, Econix Research, Analysis and Consulting Inc.
Igor Korobko, Head of Science and Innovative Development of Health Department, Ministry of Health of the Russian Federation (online)
Elena Maksimkina, Director, Federal Center for Planning and Regulation of Medical Supply Circulation of the Ministry of Health of the Russian Federation
Inga Nizharadze, General Director, Skopinpharm
Vitaliy Omelyanovskiy, General Director, Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation
Aleksandr Tkachenko, Archipiest; Chairman of the Committee of Charity and Social Work of the Civic Chamber of the Russian Federation; Chairman of the Board, Circle of Kindness Foundation
Oleg Ergashev, Vice-Governor of Saint Petersburg

Front row participant
Alexey Kosolapov, Commercial Director, Alexion Pharmaceuticals

Broadcast